A Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and High-Grade Large B-Cell Lymphoma

Clinical trial NCT04313608 · COMPLETED

Trial details

NCT number: NCT04313608
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Lymphoma

Start date: 2020-06-04
Primary completion: 2021-10-26
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.